Human Longevity

Company

Investment-firm

Last deal

$39.8M

Amount

Series B

Stage

21.08.2024

Date

6

all rounds

$380.3M

Total amount

General

About Company
Human Longevity is a genomic-based health intelligence company that empowers proactive healthcare and enables a better life.

Industry

Sector :

Subsector :

Keywords :

Also Known As

HLI

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

By combining the largest database of genomic and phenotypic data with machine learning, Human Longevity aims to revolutionize medicine. Their business areas include HLI Health Nucleus, a clinical research center that provides a complete picture of individual health, and HLIQ Whole Genome and HLIQ Oncology, which use computing and machine learning to generate personalized health insights. Founded in 2013 and headquartered in San Diego, California, HLI is focused on compiling and analyzing more genotypic and phenotypic data to accelerate our understanding of what makes us who we are and what we can change for a life better lived.
Contacts

Phone number

Social url